CBUS
CBUS
NASDAQ · Biotechnology

Cibus Inc

$2.08
-0.16 (-7.14%)
As of Feb 8, 2:09 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 51.03M 53.29M 43.77M
Net Income -10,998,457 -9,463,863 -8,925,272
EPS
Profit Margin -21.6% -17.8% -20.4%
Rev Growth +21.4% -6.8% -0.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 16.51M 18.77M 16.29M
Total Equity 77.21M 92.82M 86.26M
D/E Ratio 0.21 0.20 0.19
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -12,398,986 -11,859,784 -9,126,722
Free Cash Flow -10,819,178 -9,841,834 -11,921,306